0.35
전일 마감가:
$0.3193
열려 있는:
$0.3225
하루 거래량:
2.07M
Relative Volume:
0.26
시가총액:
$51.30M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-0.5385
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
+11.93%
1개월 성능:
+33.59%
6개월 성능:
-67.29%
1년 성능:
-80.23%
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
BDSX
Biodesix Inc
|
0.35 | 45.83M | 49.09M | -52.15M | -45.93M | -0.65 |
![]()
TMO
Thermo Fisher Scientific Inc
|
404.94 | 160.56B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
188.07 | 141.52B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
520.87 | 42.74B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
112.04 | 34.11B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
158.96 | 27.70B | 15.50B | 1.33B | 2.16B | 7.34 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2024-09-16 | 개시 | Scotiabank | Sector Outperform |
2024-07-26 | 개시 | Craig Hallum | Buy |
2024-05-13 | 개시 | TD Cowen | Buy |
2024-05-03 | 개시 | Lake Street | Buy |
2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
2020-11-23 | 개시 | BTIG Research | Buy |
2020-11-23 | 개시 | Canaccord Genuity | Buy |
2020-11-23 | 개시 | Morgan Stanley | Overweight |
2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
What drives Biodesix Inc. stock priceAccelerated earnings growth - jammulinksnews.com
Is Biodesix Inc. a good long term investmentSuperior portfolio returns - Autocar Professional
What analysts say about Biodesix Inc. stockDynamic profit opportunities - Autocar Professional
Biodesix Inc. Stock Analysis and ForecastExplosive returns - jammulinksnews.com
How Biodesix Inc. stock performs during market volatilityReliable Low Risk Signals - beatles.ru
What makes Biodesix Inc. stock price move sharplySmart Trading With Safety Margin - Newser
Why Biodesix Inc. stock attracts strong analyst attentionFree Access to Investors Club - Newser
Biodesix (NASDAQ:BDSX) Trading 0.4% Higher – Time to Buy? - Defense World
Investors Give Biodesix, Inc. (NASDAQ:BDSX) Shares A 27% Hiding - 富途牛牛
Biodesix, Inc. (NASDAQ:BDSX) Short Interest Up 127.0% in May - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Stock Rockets 30% But Many Are Still Ignoring The Company - simplywall.st
Millennium Management LLC Buys 33,329 Shares of Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix (BDSX) Partners with APAPP to Enhance Lung Cancer Care - GuruFocus
Biodesix, Inc. Partners with Association of Pulmonary Advanced Practice Providers to Deliver Nation's First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - MarketScreener
Biodesix Partners with Association of Pulmonary Advanced Practic - GuruFocus
Biodesix partners with Association of Pulmonary APPs for lung cancer education - TipRanks
Public market insider buying at Freehold Royalties (FRU) - The Globe and Mail
Biodesix Partners with Association of Pulmonary Advanced - GlobeNewswire
Biodesix Partners with APAPP to Enhance Lung Cancer Education and Access to Diagnostic Tools - Nasdaq
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs - yahoo.co
Jane Street Group LLC Acquires New Holdings in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Wall Street’s big rally stalls following some discouraging economic data - The Globe and Mail
Biodesix at 45th Annual William Blair Growth Stock Conference: Lung Health Focus - Investing.com Canada
Northern Trust Corp Grows Stake in Biodesix, Inc. (NASDAQ:BDSX) - Defense World
Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - The Manila Times
Scotiabank Has Lowered Expectations for Biodesix (NASDAQ:BDSX) Stock Price - Defense World
Biodesix Announces New Data on the VeriStrat® Test to be Present - GuruFocus
Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq
Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan
Independent Director of Biodesix Picks Up 15% More Stock - Yahoo Finance
Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India
Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada
Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks
Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com
Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus
Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX Stock News - GuruFocus
Biodesix price target lowered to $2 from $3 at Scotiabank - TipRanks
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):